Lopez-Sanchez C, Lagoa R, Poejo J, Garcia-Lopez V, Garcia-Martinez V, Gutierrez-Merino C
Molecules. 2024; 29(4).
PMID: 38398528
PMC: 10893315.
DOI: 10.3390/molecules29040776.
Upadhayay S, Yedke N, Rahi V, Singh S, Kumar S, Arora A
Neurochem Res. 2023; 48(6):1631-1647.
PMID: 36738367
DOI: 10.1007/s11064-023-03868-1.
Sosnoski H, Sears S, He Y, Frare C, Hewett S
Neurochem Int. 2020; 141:104888.
PMID: 33199267
PMC: 7704737.
DOI: 10.1016/j.neuint.2020.104888.
Subramaniam S
Biochem Soc Trans. 2020; 48(2):709-717.
PMID: 32129826
PMC: 7200642.
DOI: 10.1042/BST20191283.
Sidhu A, Diwan V, Kaur H, Bhateja D, Singh C, Sharma S
Metab Brain Dis. 2018; 33(6):1911-1921.
PMID: 30054774
DOI: 10.1007/s11011-018-0297-0.
Interleukin-1β Protects Neurons against Oxidant-Induced Injury via the Promotion of Astrocyte Glutathione Production.
Chowdhury T, Allen M, Thorn T, He Y, Hewett S
Antioxidants (Basel). 2018; 7(8).
PMID: 30044427
PMC: 6115796.
DOI: 10.3390/antiox7080100.
Antioxidant and antiapoptotic actions of selegiline protect against 3-NP-induced neurotoxicity in rats.
Wahdan S, Tadros M, Khalifa A
Naunyn Schmiedebergs Arch Pharmacol. 2017; 390(9):905-917.
PMID: 28643087
DOI: 10.1007/s00210-017-1392-1.
Protective Effect of Antioxidants on Neuronal Dysfunction and Plasticity in Huntington's Disease.
Velusamy T, Panneerselvam A, Purushottam M, Anusuyadevi M, Pal P, Jain S
Oxid Med Cell Longev. 2017; 2017:3279061.
PMID: 28168008
PMC: 5266860.
DOI: 10.1155/2017/3279061.
NADPH oxidase in brain injury and neurodegenerative disorders.
Ma M, Wang J, Zhang Q, Wang R, Dhandapani K, Vadlamudi R
Mol Neurodegener. 2017; 12(1):7.
PMID: 28095923
PMC: 5240251.
DOI: 10.1186/s13024-017-0150-7.
Neuroprotective Effect of a DJ-1 Based Peptide in a Toxin Induced Mouse Model of Multiple System Atrophy.
Glat M, Ben-Zur T, Barhum Y, Offen D
PLoS One. 2016; 11(2):e0148170.
PMID: 26901405
PMC: 4763099.
DOI: 10.1371/journal.pone.0148170.
Combination of lycopene, quercetin and poloxamer 188 alleviates anxiety and depression in 3-nitropropionic acid-induced Huntington's disease in rats.
Jain D, Gangshettiwar A
J Intercult Ethnopharmacol. 2015; 3(4):186-91.
PMID: 26401371
PMC: 4576812.
DOI: 10.5455/jice.20140903012921.
Genistein improves 3-NPA-induced memory impairment in ovariectomized rats: impact of its antioxidant, anti-inflammatory and acetylcholinesterase modulatory properties.
Menze E, Esmat A, Tadros M, Abdel-Naim A, Khalifa A
PLoS One. 2015; 10(2):e0117223.
PMID: 25675218
PMC: 4326416.
DOI: 10.1371/journal.pone.0117223.
Involvement of the up-regulated FoxO1 expression in follicular granulosa cell apoptosis induced by oxidative stress.
Shen M, Lin F, Zhang J, Tang Y, Chen W, Liu H
J Biol Chem. 2012; 287(31):25727-40.
PMID: 22669940
PMC: 3406661.
DOI: 10.1074/jbc.M112.349902.
3-Nitropropionic acid as a tool to study the mechanisms involved in Huntington's disease: past, present and future.
Tunez I, Tasset I, Perez-De la Cruz V, Santamaria A
Molecules. 2010; 15(2):878-916.
PMID: 20335954
PMC: 6263191.
DOI: 10.3390/molecules15020878.
Pyrroloquinoline quinone stimulates mitochondrial biogenesis through cAMP response element-binding protein phosphorylation and increased PGC-1alpha expression.
Chowanadisai W, Bauerly K, Tchaparian E, Wong A, Cortopassi G, Rucker R
J Biol Chem. 2009; 285(1):142-52.
PMID: 19861415
PMC: 2804159.
DOI: 10.1074/jbc.M109.030130.
NAP protects against cyanide-related microtubule destruction.
Zemlyak I, Sapolsky R, Gozes I
J Neural Transm (Vienna). 2009; 116(11):1411-6.
PMID: 19551468
DOI: 10.1007/s00702-009-0252-7.
Mitochondrial DNA damage is a hallmark of chemically induced and the R6/2 transgenic model of Huntington's disease.
Acevedo-Torres K, Berrios L, Rosario N, Dufault V, Skatchkov S, Eaton M
DNA Repair (Amst). 2008; 8(1):126-36.
PMID: 18935984
PMC: 3268004.
DOI: 10.1016/j.dnarep.2008.09.004.
The role of oxidative stress, metabolic compromise, and inflammation in neuronal injury produced by amphetamine-related drugs of abuse.
Yamamoto B, Raudensky J
J Neuroimmune Pharmacol. 2008; 3(4):203-17.
PMID: 18709468
PMC: 3955110.
DOI: 10.1007/s11481-008-9121-7.
Prospects for redox-based therapy in neurodegenerative diseases.
Friedlich A, Beal M
Neurotox Res. 2006; 2(2-3):229-37.
PMID: 16787843
DOI: 10.1007/BF03033796.
Neuroprotective and neurorestorative strategies for neuronal injury.
Beal M, Palomo T, Kostrzewa R, Archer T
Neurotox Res. 2006; 2(2-3):71-84.
PMID: 16787833
DOI: 10.1007/BF03033786.